Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.

作者: Kathleen Ebelt , Gregor Babaryka , Ainhoa M. Figel , Heike Pohla , Alexander Buchner

DOI: 10.1002/PROS.20661

关键词:

摘要: BACKGROUND: Prostate cancer is the most common of men in Western world. Despite over-expression tumor-associated antigens, like PSA or PSMA, immune activation inefficient. The goal this investigation was to assess situ characteristics prostate cancer-infiltrating lymphocytes and determine their status effector function. METHODS: We compared 17 carcinoma containing tissues, four benign prostatic hyperplasia tissues eight healthy regarding lymphocyte subset composition, locoregional distribution, functional using immunohistological staining cryopreserved tissues. For determination subsets, serial sections were stained with CD3, CD4, CD8 antibodies. Activation function studied CD69, interferon-gamma (IFN gamma), perforin, CD3 zeta chain T-cell-receptor repertoire (TCR) analysis made complexity infiltrating lymphocytes. RESULTS: CD3+, CD4+, CD69+ T prominent derived from patients carcinoma. CD8+ significantly less than CD4+ IFN gamma perforin downregulated on cells tissue. Very few detected within cancerous lesions whereas surrounding showed extensive cluster formation. TCR broad similar that tissue, giving no evidence for specific recruitment. CONCLUSIONS: In microenvironment, dominated while sparse. exhibited signs disturbed Consequently, response against autologous tumor likely be inefficient controlling growth.

参考文章(38)
Shahrokh F Shariat, Kevin M Slawin, Farshid Sadeghi, Vaccine-based immunotherapy for prostate cancer. Reviews in urology. ,vol. 2, pp. 222- 227 ,(2000)
Petra Jantzer, Dolores J. Schendel, Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo. Cancer Research. ,vol. 58, pp. 3078- 3086 ,(1998)
Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin, Soldano Ferrone, Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Advances in Immunology. ,vol. 74, pp. 181- 273 ,(2000) , 10.1016/S0065-2776(08)60911-6
Steven A. Rosenberg, Progress in human tumour immunology and immunotherapy Nature. ,vol. 411, pp. 380- 384 ,(2001) , 10.1038/35077246
Zun-Jiang Xie, Morphological observation of tumor infiltrating immunocytes in human rectal cancer. World Journal of Gastroenterology. ,vol. 12, pp. 1757- 1760 ,(2006) , 10.3748/WJG.V12.I11.1757
Carmen Scheibenbogen, Ulrich Keilholz, Michael Pawlita, Martina Willhauck, Eckhard Thiel, Thomas Möhler, Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy. Cancer Research. ,vol. 63, pp. 3483- 3485 ,(2003)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
Bernhard Arden, StephenP. Clark, Dieter Kabelitz, TakW. Mak, Mouse T-cell receptor variable gene segment families. Immunogenetics. ,vol. 42, pp. 455- 500 ,(1995) , 10.1007/BF00172176
David Sancho, Manuel Gómez, Francisco Sánchez-Madrid, CD69 is an immunoregulatory molecule induced following activation. Trends in Immunology. ,vol. 26, pp. 136- 140 ,(2005) , 10.1016/J.IT.2004.12.006